SOD1 and schizophrenia: In the remission schizophrenia group, SOD activity of IgGs was comparable in individuals with leading positive and negative symptoms (23.68 (16.34; 43.59) and 27.71 (17.72; 46.60) μM diformazan/min/IgG mg, respectively; p = 0.938; Figure 5A).